Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins

by Chen Zhao, Haripriya Sridharan, Ran Chen, Darren P. Baker, Shanshan Wang, Robert M. Krug
Published 2016-09-01

Pathogenic Effects of IFIT2 and Interferon-β during Fatal Systemic Candida albicans Infection

by Marcin Stawowczyk, Shamoon Naseem, Valeria Montoya, Darren P. Baker, James Konopka, Nancy C. Reich, Christine A. Biron
Published 2018-04-01

Pathogen recognition receptor signaling accelerates phosphorylation-dependent degradation of IFNAR1.

by Juan Qian, Hui Zheng, Wei-Chun Huangfu, Jianghuai Liu, Christopher J Carbone, N Adrian Leu, Darren P Baker, Serge Y Fuchs
Published 2011-06-01

Efficacy and Safety of Teriflunomide in Multiple Sclerosis across Age Groups: Analysis from Pooled Pivotal and Real-world Studies

by Jiwon Oh, Sandra Vukusic, Klaus Tiel-Wilck, Jihad Said Inshasi, David Rog, Darren P Baker, Yelena Pyatkevich, Elizabeth M Poole, Patrick Vermersch
Published 2021-07-01

A Rapid Screening Assay Identifies Monotherapy with Interferon-ß and Combination Therapies with Nucleoside Analogs as Effective Inhibitors of Ebola Virus.

by Stephen D S McCarthy, Beata Majchrzak-Kita, Trina Racine, Hannah N Kozlowski, Darren P Baker, Thomas Hoenen, Gary P Kobinger, Eleanor N Fish, Donald R Branch
Published 2016-01-01

Influenza virus non-structural protein 1 (NS1) disrupts interferon signaling.

by Danlin Jia, Ramtin Rahbar, Renee W Y Chan, Suki M Y Lee, Michael C W Chan, Ben Xuhao Wang, Darren P Baker, Bing Sun, J S Malik Peiris, John M Nicholls, Eleanor N Fish
Published 2010-11-01

Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, single-arm proof-of-concept trial.

by Mandy Kader Konde, Darren P Baker, Fode Amara Traore, Mamadou Saliou Sow, Alioune Camara, Alpha Amadou Barry, Doussou Mara, Abdoulaye Barry, Moussa Cone, Ibrahima Kaba, Amento Ablam Richard, Abdoul Habib Beavogui, Stephan Günther, European Mobile Laboratory Consortium, Melania Pintilie, Eleanor N Fish
Published 2017-01-01

Central Role of ULK1 in Type I Interferon Signaling

by Diana Saleiro, Swarna Mehrotra, Barbara Kroczynska, Elspeth M. Beauchamp, Pawel Lisowski, Beata Majchrzak-Kita, Tushar D. Bhagat, Brady L. Stein, Brandon McMahon, Jessica K. Altman, Ewa M. Kosciuczuk, Darren P. Baker, Chunfa Jie, Nadereh Jafari, Craig B. Thompson, Ross L. Levine, Eleanor N. Fish, Amit K. Verma, Leonidas C. Platanias
Published 2015-04-01

Best Practices for Long-Term Monitoring and Follow-Up of Alemtuzumab-Treated MS Patients in Real-World Clinical Settings

by Krista Barclay, Robert Carruthers, Anthony Traboulsee, Ann D. Bass, Christopher LaGanke, Antonio Bertolotto, Aaron Boster, Elisabeth G. Celius, Jérôme de Seze, Dionisio Dela Cruz, Mario Habek, Jong-Mi Lee, Volker Limmroth, Sven G. Meuth, Celia Oreja-Guevara, Patricia Pagnotta, Cindy Vos, Tjalf Ziemssen, Darren P. Baker, Bart Van Wijmeersch
Published 2019-03-01